✦ LIBER ✦

Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies

✍ Scribed by Schmeler, Kathleen M.; Wilson, Ginger L.; Cain, Katherine; Munsell, Mark F.; Ramirez, Pedro T.; Soliman, Pamela T.; Nick, Alpa M.; Frumovitz, Michael; Coleman, Robert L.; Kroll, Michael H.; Levenback, Charles F.

Book ID: 123249562
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 169 KB
Volume: 128
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.11.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in venous thromboembolism (VTE

Reduction in venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies

✍ K. Schmeler; G. Langley; K. Cain; M. Munsell; P. Ramirez; P. Soliman; A. Nick; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Patient costs associated with extended-d

Patient costs associated with extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer

✍ K. Cain; G. Langley; O. Max; P. Ramirez; C. Levenback; K. Schmeler 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Patient cost associated with filling a p

Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer

✍ Katherine Cain; Kathleen M. Schmeler; Ginger Langley; Oliver Max; Pedro T. Ramir 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Timing, Incidence and Risk Factors for V

Timing, Incidence and Risk Factors for Venous Thromboembolism in Patients Undergoing Radical Cystectomy for Malignancy: A Case for Extended Duration Pharmacological Prophylaxis

✍ VanDlac, Amanda A.; Cowan, Nick G.; Chen, Yiyi; Anderson, Ross E.; Conlin, Micha 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 187 KB

PCV90 COST EFFECTIVENESS OF FONDAPARINUX

PCV90 COST EFFECTIVENESS OF FONDAPARINUX COMPARED WITH ENOXAPARIN FOR EXTENDED PROPHYLAXIS AGAINST VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING HIP FRACTURE SURGERY USING DUTCH ESTIMATES OF COSTS

✍ B Van Hout; BV Pharmerit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCV89 COST-EFFECTIVENESS OF AN EXTENDED

PCV89 COST-EFFECTIVENESS OF AN EXTENDED FOUR-WEEK FONDAPARINUX PROPHYLAXIS REGIMEN FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS UNDERGOING MAJOR ORTHOPEDIC SURGERY

✍ M Bischof; P Sendi; J Leuppi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB